233 related articles for article (PubMed ID: 12348220)
21. Oral contraceptives and venous thromboembolism: should epidemiologic associations drive clinical decision making?
Westhoff CL
Contraception; 1996 Jul; 54(1):1-3. PubMed ID: 8804800
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of venous thromboembolic disease and OC use.
Ory HW
Dialogues Contracept; 1996; 5(1):4-7, 10. PubMed ID: 12347722
[TBL] [Abstract][Full Text] [Related]
23. Desogestrel, norgestimate, and gestodene: the newer progestins.
Kaplan B
Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
[TBL] [Abstract][Full Text] [Related]
24. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
[TBL] [Abstract][Full Text] [Related]
25. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status.
Potts M; Denny C
Drug Saf; 1995 Dec; 13(6):333-7. PubMed ID: 8652077
[TBL] [Abstract][Full Text] [Related]
26. Third-generation OCs safe, health officials say.
Contracept Technol Update; 1999 Dec; 20(12):140-1. PubMed ID: 12295559
[TBL] [Abstract][Full Text] [Related]
27. [Metrorrhagia caused by estrogen-progestin combinations].
Erny R; Erny N
Contracept Fertil Sex (Paris); 1994 Feb; 22(2):93-7. PubMed ID: 12319056
[TBL] [Abstract][Full Text] [Related]
28. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
29. Selective prescribing of third generation oral contraceptives (OCs).
Jamin C; de Mouzon J
Contraception; 1996 Jul; 54(1):55-6. PubMed ID: 8804809
[TBL] [Abstract][Full Text] [Related]
30. Coagulation and thrombosis with OC use: physiology and clinical relevance.
Comp PC
Dialogues Contracept; 1996; 5(1):1-3. PubMed ID: 12347721
[TBL] [Abstract][Full Text] [Related]
31. On 7/7/7 preferred for new patients by 47% of respondents.
Contracept Technol Update; 1986 Sep; 7(9):101-4. PubMed ID: 12268337
[TBL] [Abstract][Full Text] [Related]
32. Third-generation oral contraceptives: how risky?
Weiss N
Lancet; 1995 Dec; 346(8990):1570. PubMed ID: 7500743
[TBL] [Abstract][Full Text] [Related]
33. Modern oral contraceptives and cardiovascular disease.
Rosenberg L; Palmer JR; Sands MI; Grimes D; Bergman U; Daling J; Mills A
Am J Obstet Gynecol; 1997 Sep; 177(3):707-15. PubMed ID: 9322646
[TBL] [Abstract][Full Text] [Related]
34. Effect of the British warning on contraceptive use in the General Medical Service in Ireland.
Williams D; Kelly A; Carvalho M; Feely J
Ir Med J; 1998 Dec; 91(6):202-3. PubMed ID: 10069128
[TBL] [Abstract][Full Text] [Related]
35. [Oral contraception: evolution of concepts over the last thirty years].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1987 Nov; 15(11 Suppl):1-8. PubMed ID: 12281408
[TBL] [Abstract][Full Text] [Related]
36. Attitudes, regulations hinder use of the pill.
Townsend S
Netw Res Triangle Park N C; 1993 Mar; 13(3):6-10. PubMed ID: 12318101
[TBL] [Abstract][Full Text] [Related]
37. Venous thromboembolism among new users of different oral contraceptives.
Herings RM; Urquhart J; Leufkens HG
Lancet; 1999 Jul; 354(9173):127-8. PubMed ID: 10408492
[TBL] [Abstract][Full Text] [Related]
38. [Oral contraception and circulatory risks].
Wingrave SJ
Contracept Fertil Sex (Paris); 1984 Oct; 12(10):1111-6. PubMed ID: 12266560
[TBL] [Abstract][Full Text] [Related]
39. The risk of venous thromboembolism in users of postcoital contraceptive pills.
Vasilakis C; Jick SS; Jick H
Contraception; 1999 Feb; 59(2):79-83. PubMed ID: 10361621
[TBL] [Abstract][Full Text] [Related]
40. Designating types of OCs in family planning agency can save money.
Contracept Technol Update; 1985 Jan; 6(1):6-7. PubMed ID: 12279917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
